Clinical Trials Directory

Trials / Completed

CompletedNCT05815407

Expressiona and Diagnostic Potential of miRNAs in NSCLC

The Expression Profiling of Serum miRNAs (106b-5p, 601, and 760) in Non-small Cell Lung Cancer Patients

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Its to explore the expression pattern, diagnostic and prognostic potentials of miRs (106b-5p, 601 and 760) in serum of NSCLC patients

Detailed description

A retrospective observational study on NSCLC patients, to determine the serum expression levels if some miRNAs in NSCLC patients and to find if having proper diagnostic and prognostic values in early disease detection, and/or staging.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention

Timeline

Start date
2018-09-01
Primary completion
2022-09-30
Completion
2022-09-30
First posted
2023-04-18
Last updated
2023-04-18

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05815407. Inclusion in this directory is not an endorsement.